ARBUTUS BIOPHARMA CORP earnings per share and revenue

I9DN earnings per share for the last quarter are -0.09 EUR whereas the estimation was -0.10 EUR which accounts for 9.09% surprise. Company revenue for the same period amounts to 1.42 M EUR despite the estimated figure of 2.52 M EUR. Estimated earnings per share for the next quarter are -0.09 EUR, and revenue is expected to reach 1.65 M EUR. Also watch annual changes over time to get a bigger picture of I9DN earnings per share and revenue dynamics.